Connect
MJA
MJA

Medication overuse headache in Australia: a call for multidisciplinary efforts at prevention and treatment

Richard J Stark, Treasure McGuire and Mieke L van Driel
Med J Aust 2016; 205 (6): 283. || doi: 10.5694/mja16.00492
Published online: 19 September 2016

Medication overuse headache (MOH)1 is prevalent, under-recognised and potentially treatable or avoidable using a multidisciplinary approach.

  • Richard J Stark1,2
  • Treasure McGuire3,4
  • Mieke L van Driel3

  • 1 Neurology Service, Alfred Health, Melbourne, VIC
  • 2 Department of Medicine, Monash University, Melbourne, VIC
  • 3 University of Queensland, Brisbane, QLD
  • 4 Bond University, Gold Coast, QLD

Correspondence: Richard.stark@monash.edu

Acknowledgements: 

We thank Esther Anderson of In Vivo Communications for her assistance in medical writing.

Competing interests:

Richard Stark has received lecture and consulting fees from Allergan, MSD, AbbVie and SciGen, and from In Vivo Academy relating to a Pfizer-sponsored project. He has also undertaken clinical trials for Allergan.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.